Technetium-99m-HmPAO brain spect in infantile Gaucher's disease

Pediatric Neurology

Volumn 20, Issue 1, 1999, Pages 66-69

  Lin, Dar Shong ^a   Lin, Shuan Pei ^a   Liang, Der Cherg ^b   Ho, Che Sheng ^d   Wu, Ming Che ^e  

^a Div Genet Dept Pediat M   (Taiwan)

^b

^c Taiwan

^d Division of Neurology   (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ARTICLE; BRAIN BLOOD FLOW; BRAIN DISEASE; BRAIN METABOLISM; CASE REPORT; GAUCHER DISEASE; HUMAN; INFANT; MALE; METABOLIC DISORDER; NEURORADIOLOGY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ATROPHY; BRAIN; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DISEASE PROGRESSION; GAUCHER DISEASE; HUMANS; INFANT; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032928743     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(98)00101-5     Document Type: Article

References (13)

1. Beutler E., Grabowski G.A. Gaucher disease. Scriver C.R., Beaudet A.L., Sly W., Valle D. The metabolic and molecular bases of inherited disease. 7th ed. 1995;2641-2670 McGraw-Hill, New York.
2. Knudson A.G., Kaplan W.D. Genetics of sphingolipidoses. Aronson S.M., Volk B.W. Cerebral sphingolipidoses. 1962;395-411 Academic Press, New York.
3. Nilson O., Svennerholm L. Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease. J Neurochem. 39:1982;709-718.
4. Bove K.E., Daugherty C., Grabowski G.A. Pathological findings in Gaucher disease type 2 patients following enzyme therapy. Hum Pathol. 26:1995;1040-1045.
5. Lee R.E. The pathology of Gaucher disease. Prog Clin Biol Res. 95:1982;177-217.
6. Tsai P., Lipton J.M., Sahdev I., et al. Allogenic bone marrow transplantation in severe Gaucher disease. Pediatr Res. 31:1992;503-507.
7. Grabowski G.A., Barton N.W., Doppelt S.H. A clinician's guide to Gaucher disease A treatment algorithm . 1994;1-22 Gardiner-Caldwell SynerMed, Califon, NJ.
8. Erikson A., Johansson K., Mansson J.E., Svennerholm L. Enzyme replacement therapy of infantile Gaucher disease. Neuropediatrics. 24:1993;237-238.
9. Erikson A., Astrom M., Mansson J.E. Enzyme infusion therapy of the Norbottnian (type 3) Gaucher disease. Neuropediatrics. 26:1995;203-207.
10. Zimran A., Elstein D., Abrahamov A. Enzyme replacement therapy in type 1 and type 3 Gaucher's disease. Lancet. 345:1995;451-452.
11. Rappeport J.M., Ginns E.I. Bone marrow transplantation in severe Gaucher disease. N Engl J Med. 311:1984;84-88.
12. Ringden O., Groth C.G., Erikson A., et al. Long-term follow-up of the first successful bone marrow transplantation in Gaucher disease. Transplantation. 46:1988;66-70.
13. Erikson A., Groth C.G., Mansson J.E., Percy A., Ringden O., Svennerholm L. Clinical and biochemical outcome of marrow transplantation for Gaucher disease of Norrbottnian type. Acta Paediatr Scand. 79:1990;680-685.